Unstimulated cortisol secretory activity in everyday life and its relationship with fatigue and chronic fatigue syndrome: A systematic review and subset meta-analysis

Psychoneuroendocrinology

Volumn 38, Issue 11, 2013, Pages 2405-2422

  Powell, Daniel J H ^a   Liossi, Christina ^a   Moss Morris, Rona ^a,b   Schlotz, Wolff ^a,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Ambulatory assessment; Chronic fatigue syndrome; Cortisol; Fatigue; HPA axis; Meta analysis; Systematic review

Indexed keywords

HYDROCORTISONE;

ADULT; BODY MASS; CHRONIC FATIGUE SYNDROME; CIRCADIAN RHYTHM; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; FATIGUE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SALIVA LEVEL; SMOKING HABIT; SYSTEMATIC REVIEW;

AMBULATORY ASSESSMENT; CHRONIC FATIGUE SYNDROME; CORTISOL; FATIGUE; HPA AXIS; META-ANALYSIS; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FATIGUE; FATIGUE SYNDROME, CHRONIC; HUMANS; HYDROCORTISONE; SALIVA; WAKEFULNESS;

EID: 84886089285     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.07.004     Document Type: Review

References (84)

1. Adam E.K., Kumari M. Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology 2009, 34:1423-1436.
2. Åhsberg E., Garnberale F., Kjellberg A. Perceived quality of fatigue during different occupational tasks. Development of a questionnaire. Int. J. Ind. Ergonom. 1997, 20:121-135.
3. Bansal A.S., Bradley A.S., Bishop K.N., Kiani-Alikhan S., Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav. Immun. 2012, 26:24-31.
4. Barnes E.A., Bruera E. Fatigue in patients with advanced cancer: a review. Int. J. Gynecol. Cancer 2002, 12:424-428.
5. Barroso J., Burrage J., Carlson J., Carlson B.W. Salivary cortisol values in HIV-positive people. J. Assoc. Nurses AIDS Care 2006, 17:29-36.
6. Barroso J., Lynn M.R. Psychometric properties of the HIV-Related Fatigue Scale. J. Assoc. Nurses AIDS Care 2002, 13:66-75.
7. Bay E., Xie Y. Psychological and biological correlates of fatigue after mild-to-moderate traumatic brain injury. West. J. Nurs. Res. 2009, 31:731-747.
8. Belza B.L. Comparison of self-reported fatigue in rheumatoid arthritis and controls. J. Rheumatol. 1995, 22:639-643.
9. Bower J.E., Ganz P.A., Dickerson S.S., Petersen L., Aziz N., Fahey J.L. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005, 30:92-100.
10. Breitbart W., McDonald M.V., Rosenfeld B., Monkman N.D., Passik S. Fatigue in ambulatory AIDS patients. J. Pain Symptom Manage. 1998, 15:159-167.
11. Cella M., Chalder T., White P.D. Does the heterogeneity of chronic fatigue syndrome moderate the response to cognitive behaviour therapy? An exploratory study. Psychother. Psychosom. 2011, 80:353-358.
12. Cella M., White P.D., Sharpe M., Chalder T. Cognitions, behaviours and co-morbid psychiatric diagnoses in patients with chronic fatigue syndrome. Psychol. Med. 2013, 43:375-380.
13. Chida Y., Steptoe A. Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. Biol. Psychol. 2009, 80:265-278.
14. Cleare A.J. The neuroendocrinology of chronic fatigue syndrome. Endocr. Rev. 2003, 24:236-252.
15. Cleare A.J. The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol. Metab. 2004, 15:55-59.
16. Cleare A.J., Heap E., Malhi G.S., Wessely S., O'Keane V., Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999, 353:455-458.
17. Clow A., Hucklebridge F., Stalder T., Evans P., Thorn L. The cortisol awakening response: more than a measure of HPA axis function. Neurosci. Biobehav. Rev. 2010, 35:97-103.
18. Clow A., Thorn L., Evans P., Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress 2004, 7:29-37.
19. Cullen W., Kearney Y., Bury G. Prevalence of fatigue in general practice. Ir. J. Med. Sci. 2002, 171:10-12.
20. Dekkers J.C., Geenen R., Godaert G.L.R., van Doornen L.J.P., Bijlsma J.W.J. Diurnal courses of cortisol, pain, fatigue, negative mood, and stiffness in patients with recently diagnosed rheumatoid arthritis. Int. J. Behav. Med. 2000, 7:353-371.
21. Demitrack M.A., Dale J.K., Straus S.E., Laue L., Listwak S.J., Kruesi M.J.P., Chrousos G.P., Gold P.W. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 1991, 73:1224-1234.
22. Ebner-Priemer U.W., Kubiak T. The decade of behavior revisited: future prospects for ambulatory assessment. Eur. J. Psychol. Assess. 2010, 26:151-153.
23. Eek F., Karlson B., Garde A.H., Hansen Å.M., Ørbæk P. Cortisol, sleep, and recovery - some gender differences but no straight associations. Psychoneuroendocrinology 2012, 37:56-64.
24. Field A., Gillett R. How to do a meta-analysis. Br. J. Math. Stat. Psychol. 2010, 63:665-694.
25. Fishbain D.A., Cutler R.B., Cole B., Lewis J., Smets E., Rosomoff H.L., Rosomoff R.S. Are patients with chronic low back pain or chronic neck pain fatigued?. Pain Med. 2004, 5:187-195.
26. Fries E., Hesse J., Hellhammer J., Hellhammer D.H. A new view on hypocortisolism. Psychoneuroendocrinology 2005, 30:1010-1016.
27. Fukuda K., Straus S., Hickie I., Sharpe M., Dobbins J., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 1994, 121:953-959.
28. Gaab J., Huster D., Peisen R., Engert V., Schad T., Schurmeyer T.H., Ehlert U. Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom. Med. 2002, 64:311-318.
29. Gold S.M., Kruger S., Ziegler K.J., Krieger T., Schulz K.H., Otte C., Heesen C. Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression. J. Neurol. Neurosurg. Psychiatry 2011, 82:814-818.
30. Hansen Å.M., Garde A.H., Persson R. Sources of biological and methodological variation in salivary cortisol and their impact on measurement among healthy adults: a review. Scand. J. Clin. Lab. Invest. 2008, 68:448-458.
31. Hays R.D., Sherbourne C.D., Mazel R.M. The RAND 36-item health survey 1.0. Health Econ. 1993, 2:217-227.
32. Heim C., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25:1-35.
33. Heim C., Nater U.M., Maloney E., Boneva R.S., Jones J.F., Reeves W.C. Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch. Gen. Psychiatry 2009, 66:72-80.
34. Hewlett S., Cockshott Z., Byron M., Kitchen K., Tipler S., Pope D., Hehir M. Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Care Res. 2005, 53:697-702.
35. Inder W.J., Prickett T.C.R., Mulder R.T. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment. Clin. Endocrinol. (Oxf.) 2005, 62:343-348.
36. Jason L., Corradi K., Torres-Harding S., Taylor R., King C. Chronic fatigue syndrome: the need for subtypes. Neuropsychol. Rev. 2005, 15:29-58.
37. Jerjes W.K., Cleare A.J., Wessely S., Wood P.J., Taylor N.F. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. J. Affect. Disord. 2005, 87:299-304.
38. Khani S., Tayek J.A. Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clin. Sci. 2001, 101:739-747.
39. Kirschbaum C., Hellhammer D.H. Salivary cortisol in psychobiological research: an overview. Neuropsychobiology 1989, 22:150-169.
40. Knorr U., Vinberg M., Kessing L.V., Wetterslev J. Salivary cortisol in depressed patients versus control persons: a systematic review and meta-analysis. Psychoneuroendocrinology 2010, 35:1275-1286.
41. Krupp L.B., Serafin D.J., Christodoulou C. Multiple sclerosis-associated fatigue. Expert Rev. Neurother. 2010, 10:1437-1447.
42. Kumari M., Badrick E., Chandola T., Adam E.K., Stafford M., Marmot M.G., Kirschbaum C., Kivimaki M. Cortisol secretion and fatigue: associations in a community based cohort. Psychoneuroendocrinology 2009, 34:1476-1485.
43. Lerdal A., Celius E.G., Moum T. Fatigue and its association with sociodemographic variables among multiple sclerosis patients. Mult. Scler. 2003, 9:509-514.
44. Lerdal A., Gulowsen Celius E., Krupp L., Dahl A.A. A prospective study of patterns of fatigue in multiple sclerosis. Eur. J. Neurol. 2007, 14:1338-1343.
45. Lindeberg S.I., Eek F., Lindbladh E., Östergren P.-O., Hansen Å.M., Karlson B. Exhaustion measured by the SF-36 vitality scale is associated with a flattened diurnal cortisol profile. Psychoneuroendocrinology 2008, 33:471-477.
46. Marmot M., Brunner E. Cohort profile: the Whitehall II study. Int. J. Epidemiol. 2005, 34:251-256.
47. McGrath R.E. When effect sizes disagree: the case of r and d. Psychol. Methods 2006, 11:386-401.
48. McKenzie R., O'Fallon A., Dale J., Demitrack M., Sharma G., Deloria M., Garcia-Borreguero D., Blackwelder W., Straus S.E. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 1998, 280:1061-1066.
49. McLean S.A., Williams D.A., Harris R.E., Kop W.J., Groner K.H., Ambrose K., Lyden A.K., Gracely R.H., Crofford L.J., Geisser M.E., Sen A., Biswas P., Clauw D.J. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum. 2005, 52:3660-3669.
50. Nater U.M., Maloney E., Boneva R.S., Gurbaxani B.M., Lin J.-M., Jones J.F., Reeves W.C., Heim C. Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls. J. Clin. Endocrinol. Metab. 2008, 93:703-709.
51. Oullet M., Morin C. Fatigue following traumatic brain injury: frequency, characteristics, and associated factors. Rehabil. Psychol. 2006, 51:140-149.
52. Papadopoulos A., Cleare A.J. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat. Rev. Endocrinol. 2012, 8:22-32.
53. Papadopoulos A., Ebrecht M., Roberts A.D.L., Poon L., Rohleder N., Cleare A.J. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5mg) dexamethasone suppression test. J. Affect. Disord. 2009, 112:289-294.
54. Pawlikowska T., Chalder T., Hirsch S.R., Wallace P., Wright D.J.M., Wessely S.C. Population based study of fatigue and psychological distress. Br. Med. J. 1994, 308:763-766.
55. Poteliakhoff A. Adrenocortical activity and some clinical findings in acute and chronic fatigue. J. Psychosom. Res. 1981, 25:91-95.
56. Pruessner J.C., Kirschbaum C., Meinlschmid G., Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003, 28:916-931.
57. Rahman K., Burton A., Galbraith S., Lloyd A., Vollmer-Conna U. Sleep-wake behavior in chronic fatigue syndrome. Sleep 2011, 34:671-678.
58. Repping-Wuts H., Uitterhoeve R., van Riel P., van Achterberg T. Fatigue as experienced by patients with rheumatoid arthritis (RA): a qualitative study. Int. J. Nurs. Stud. 2008, 45:995-1002.
59. Ricci J.A., Chee E., Lorandeau A.L., Berger J. Fatigue in the U.S. workforce: prevalence and implications for lost productive work time. J. Occup. Environ. Med. 2007, 49:1-10.
60. Roberts A.D.L., Wessely S., Chalder T., Papadopoulos A., Cleare A.J. Salivary cortisol response to awakening in chronic fatigue syndrome. Br. J. Psychiatry 2004, 184:136-141.
61. Rosenthal R. The file drawer problem and tolerance for null results. Psychol. Bull. 1979, 86:638-641.
62. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 2000, 21:55-89.
63. Schlotz W. Ambulatory psychoneuroendocrinology: assessing salivary cortisol and other hormones in daily life. Handbook of Research Methods for Studying Daily Life 2011, Guilford Press, New York, NY. M.R. Mehl, T.S. Conner (Eds.).
64. Sephton S., Spiegel D. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease?. Brain Behav. Immun. 2003, 17:321-328.
65. Sharpe M.C., Archard L.C., Banatvala J.E., Borysiewicz L.K., Clare A.W., David A., Edwards R.H., Hawton K.E., Lambert H.P., Lane R.J., et al. A report - chronic fatigue syndrome: guidelines for research. J. R. Soc. Med. 1991, 84:118-121.
66. Smets E.M.A., Garssen B., Bonke B., De Haes J.C.J.M. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 1995, 39:315-325.
67. Stone A.A., Shiffman S. Ecological momentary assessment (EMA) in behavioral medicine. Ann. Behav. Med. 1994, 16:199-202.
68. Strickland P., Morriss R., Wearden A., Deakin B. A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. J. Affect. Disord. 1998, 47:191-194.
69. Sudhaus S., Fricke B., Stachon A., Schneider S., Klein H., von During M., Hasenbring M. Salivary cortisol and psychological mechanisms in patients with acute versus chronic low back pain. Psychoneuroendocrinology 2009, 34:513-522.
70. Sullivan P.S., Dworkin M.S. Prevalence and correlates of fatigue among persons with HIV infection. J. Pain Symptom Manage. 2003, 25:329-333.
71. Tak L.M., Cleare A.J., Ormel J., Manoharan A., Kok I.C., Wessely S., Rosmalen J.G.M. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol. Psychol. 2011, 87:183-194.
72. Torres-Harding S., Sorenson M., Jason L., Reynolds N., Brown M., Maher K., Fletcher M.A. The associations between basal salivary cortisol and illness symptomatology in chronic fatigue syndrome. J. Appl. Biobehav. Res. 2008, 13:157-180.
73. Trull T.J., Ebner-Priemer U. Ambulatory assessment. Annu. Rev. Clin. Psychol. 2013, 9:151-176.
74. Valentine J.C., Pigott T.D., Rothstein H.R. How many studies do you need?. J. Educ. Behav. Stat. 2010, 35:215-247.
75. van't Leven M., Zielhuis G.A., van der Meer J.W., Verbeek A.L., Bleijenberg G. Fatigue and chronic fatigue syndrome-like complaints in the general population. Eur. J. Public Health 2010, 20:251-257.
76. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 1992, 30:473-483.
77. Wessely S. Chronic fatigue: symptom and syndrome. Ann. Intern. Med. 2001, 134:838-843.
78. Wessely S., Chalder T., Hirsch S., Wallace P., Wright D. Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting. Am. J. Psychiatry 1996, 153:1050-1059.
79. Wessely S., Chalder T., Hirsch S., Wallace P., Wright D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am. J. Public Health 1997, 87:1449-1455.
80. White K., Speechley M., Harth M., Ostbye T. Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population: a controlled study. Scand. J. Rheumatol. 2000, 29:44-51.
81. Whitehead L. The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J. Pain Symptom Manage. 2009, 37:107-128.
82. Wilhelm I., Born J., Kudielka B.M., Schlotz W., Wüst S. Is the cortisol awakening rise a response to awakening?. Psychoneuroendocrinology 2007, 32:358-366.
83. Wood B., Wessely S., Papadopoulos A., Poon L., Checkley S. Salivary cortisol profiles in chronic fatigue syndrome. Neuropsychobiology 1998, 37:1-4.
84. Young A.H., Sharpe M., Clements A., Dowling B., Hawton K.E., Cowen P.J. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia). Biol. Psychiatry 1998, 43:236-237.